Mammoth Biosciences is a biotechnology company focused on developing CRISPR-based technologies for therapeutics. CRISPR-based technologies are designed to be used in gene editing to modify, delete, or correct precise regions of DNA to potentially cure diseases like sickle cell disease or muscular dystrophy. Mammoth holds an exclusive license to a family of CRISPR proteins called CasĪ¦, potentially offering enhanced precision in gene editing.
